Hi Twin,
OBJ’s have developed new magnetic microarrays that produce the best possible performance enhancement for three key proprietary molecules used by P&G across a number of their global product platforms.
Olay Regenerist is the largest selling product platform for the Olay brand, which I think would be a no-brainer where OBJ's early independent study results in the anti-aging space is concerned, however importantly if the key proprietary molecules that OBJ are super-charging form part of the ingredients found in a larger number of products across P&G's range of skin care brands, then a +$1b dollar product platform like Olay Regenerist is only going to make up a small part of the bigger picture.
All the more reason why OBJ have executed a master License that will apply to all new products developed under the PDA and work plans for the development of the first three products.
Some appear to be up in arms over some words written by a broker which others here would've accepted as just stating the obvious, however one could also ask why the broker is down-playing the potential so much by indicating that OBJ are only working on two products from only one of P&G's business units when OBJ have been informing the market for over three and a half years now that they are working on multiple products across multiple product categories with P&G.28 September 2010
"OBJ Limited announced today that it has executed a Letter of Intent to establish a Strategic Alliance program with one of the world's leading Consumer Products companies for the evaluation of OBJ technologies across multiple product categories. The Letter of Intent for the Strategic Alliance sets out a program of technical evalutions that, if successful, should lead to an initial 5 year Strategic Alliance for the design and development of a wide range of consumer products incorporating OBJ’s micro-array and FIM drug delivery technologies."
- Forums
- ASX - By Stock
- WFL
- p&g trademark search
p&g trademark search, page-70
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online